Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification and validation of RB1 as an immune-related prognostic signature based on tumor mutation burdens in bladder cancer.

Anti-cancer drugs - 1 Feb 2023

Liu Ning, Wu Tiange, Ma Yuexian, Cheng Hong, Li Wenchao, Chen Ming

Abstract excerpt

Bladder cancer (BCa) is one of the most common malignant tumors in the urinary system. Developing effective prognostic gene and exploring the immune cells that affect the prognosis of tumor are required. Full transcriptome data ( n = 433), clinical information ( n = 581) and mutation sequencing ( n = 412) were obtained from The Cancer Genome Atlas and independent mutation sequencing data of 101 samples were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Kaplan-Meier Estimate
Share to Mutation
Share to Prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Retinoblastoma Binding Proteins

Share to Ubiquitin-Protein Ligases

Share to Urinary Bladder Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 36206128
DOI: 10.1097/CAD.0000000000001399
PMCID: PMC9815815

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification and validation of RB1 as an immune-related prognostic signature based on tumor mutation burdens in bladder cancer.PMID 36206128Read ↗

Identification of RB1 Gene as a Immune-Related Prognostic Signature Based on Tumor Mutation Burdens in Bladder CancerSemantic proximity Read ↗

The Immunogenomic Landscape of and Immune Cell Infiltration in Bladder CancerSemantic proximity Read ↗

Integrative analysis of immune molecular subtypes and microenvironment characteristics of bladder cancer.Semantic proximity Read ↗

Identification of subgroups of bladder cancer based on immune gene signatureSemantic proximity Read ↗

Multi-omics analysis of tumor mutation burden combined with immune infiltrates in bladder urothelial carcinoma.Semantic proximity Read ↗

Prognostic Value of Immune-Related Genes in the Tumor Microenvironment of Bladder CancerSemantic proximity Read ↗

Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancerSemantic proximity Read ↗

Prognostic Value of Interferon-γ-Related Signature Involved in Tumor Immune Infiltration in Bladder CancerSemantic proximity Read ↗

Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer.Semantic proximity Read ↗

A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer.Semantic proximity Read ↗

FGFR3 mutation characterization identifies prognostic and immune-related gene signatures in bladder cancer.Semantic proximity Read ↗

Development of A Prognostic Index and Screening of Prognosis Related Genes Based on an Immunogenomic Landscape Analysis of Bladder CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.